Viruses and telomerase;Virus et télomérase

Virologie

Volumn 9, Issue 6, 2005, Pages 443-455

  Fragnet, L ^a   Rasschaert, D ^a  

^a CEMAGREF   (France)

Author keywords

Post translational; Telomerase; Transcriptional regulation; Virus; vTR

Indexed keywords

TELOMERASE; VIRUS RNA;

AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CHICKEN; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; GENE TARGETING; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; NONHUMAN; PAPILLOMA VIRUS; PAPOVAVIRUS; POLYOMA VIRUS; RETROVIRUS; REVERSE TRANSCRIPTION; REVIEW; RNA TRANSLATION; T CELL LYMPHOMA; T LYMPHOCYTE; TELOMERE; TERT GENE; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION;

AVES; GALLUS GALLUS; HEPATITIS C VIRUS; HERPESVIRIDAE; MARDIVIRUS; PAPILLOMAVIRIDAE; PAPOVAVIRIDAE; POLYOMAVIRUS; SIMPLEXVIRUS;

EID: 30344485959     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-13.
2. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
3. Blasco MA, Hahn WC. Evolving views of telomerase and cancer. Trends Cell Biol 2003; 13: 289-94.
4. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.
5. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 5: 1164-70.
6. Parkinson KE. Telomerase as a target for cancer therapy. Curr Opin Investig Drugs 2005; 6: 605-10.
7. Fragnet L, Blasco MA, Klapper W, Rasschaert D. The RNA subunit of telomerase is encoded by Marek's disease virus. J Virol 2003; 77: 5985-96.
8. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-73.
9. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-82.
10. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3: 1271-4.
11. Bryan TM, Goodrich KJ, Cech TR. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol Cell 2000; 6: 493-9.
12. Moriarty TJ, Marie-Egyptienne DT, Autexier C. Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer. Mol Cell Biol 2004; 24: 3720-33.
13. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59: 551-7.
14. Kyo S, Takakura M, Taira T, et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000; 28: 669-77.
15. Yago M, Ohki R, Hatakeyama S, Fujita T, Ishikawa F. Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomerase. FEBS Lett 2002; 520: 40-6.
16. Oh S, Song YH, Yim J, Kim TK. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 2000; 19: 1485-90.
17. Zhou C, Liu J. Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells. Biochem Biophys Res Commun 2003; 303: 130-6.
18. Yang H, Kyo S, Takatura M, Sun L. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Cell Growth Differ 2001; 12: 119-27.
19. Yokoyama Y, Wan X, Takahashi Y, Shinohara A, Tamaya T. Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus. Mol Hum Reprod 2001; 7: 853-7.
20. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 2000; 85: 330-5.
21. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001; 91: 644-9.
22. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000; 2: 426-32.
23. Rohde V, Sattler HP, Bund T, et al. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue. Clin Cancer Res 2000; 6: 4803-9.
24. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 1999; 96: 5147-52.
25. Liu K, Hodes RJ, Weng N. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001; 166: 4826-30.
26. Kang SS, Kwon T, Kwon DY, Do SI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999; 274: 13085-90.
27. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001; 493: 21-5.
28. Li H, Zhao L, Yang Z, Funder JW, Liu JP. Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 1998; 273: 33436-42.
29. Liu WJ, Jiang JF, Xiao D, Ding J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem Pharmacol 2002; 64: 1677-87.
30. Kharbanda S, Kumar V, Dhar S, et al. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr Biol 2000; 10: 568-75.
31. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomerase RNA. Cell 2000; 100: 503-14.
32. Ly H, Blackburn EH, Parslow TG. Comprehensive structure-function analysis of the core domain of human telomerase RNA. Mol Cell Biol 2003; 23: 6849-56.
33. Ly H, Xu L, Rivera MA, Parslow TG, Blackburn EH. A role for a novel 'trans-pseudoknot' RNA-RNA interaction in the functional dimerization of human telomerase. Genes Dev 2003; 17: 1078-83.
34. Leeper T, Leulliot N, Varani G. The solution structure of an essential stem-loop of human telomerase RNA. Nucleic Acids Res 2003; 31: 2614-21.
35. Bachand F, Autexier C. Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol Cell Biol 2001; 21: 1888-97.
36. Martin-Rivera L, Blasco MA. Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J Biol Chem 2001; 276: 5856-65.
37. Mitchell JR, Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol Cell 2000; 6: 361-71.
38. Autexier C, Pruzan R, Funk WD, Greider CW. Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J 1996; 15: 5928-35.
39. Lukowiak AA, Narayanan A, Li ZH, Terns RM, Terns MP. The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus. RNA 2001; 7: 1833-44.
40. Narayanan A, Lukowiak A, Jady BE, et al. Nucleolar localization signals of box H/ACA small nucleolar RNAs. EMBO J 1999; 18: 5120-30.
41. Harrington L. Biochemical aspects of telomerase function. Cancer Lett 2003; 194: 139-54.
42. Pogacic V, Dragon F, Filipowicz W. Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol 2000; 20: 9028-40.
43. Liu Y, Snow BE, Hande MP, et al. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo. Mol Cell Biol 2000; 20: 8178-84.
44. Le S, Sternglanz R, Greider CW. Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell 2000; 11: 999-1010.
45. Ford LP, Shay JW, Wright WE. The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo. RNA 2001; 7: 1068-75.
46. Ford LP, Wright WE, Shay JW. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 2002; 21: 580-3.
47. Zhao JQ, Glasspool RM, Hoare SF, Bilsland A, Szatmari I, Keith WN. Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia 2000; 2: 531-9.
48. Strauss M, Hering S, Lubbe L, Griffin BE. Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens. Oncogene 1990; 5: 1223-9.
49. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.
50. 50. Veldman T, Liu X, Yuan H, Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci USA 2003; 100: 8211-6.
51. McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 2003; 77: 9852-61.
52. Liu X, Yuan H, Fu B, et al. The E6-AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 2005.
53. Gao X, Mohsin SK, Gatalica Z, Fu G, Sharma P, Nawaz Z. Decreased expression of E6-AP in breast and prostate carcinomas. Endocrinology 2005; 146: 1707-12.
54. Xiong J, Fan S, Meng Q, et al. BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 2003; 23: 8668-90.
55. Gewin L, Myers H, Kiyono T, Galloway DA. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 2004; 18: 2269-82.
56. Ferber MJ, Montoya DP, Yu C, et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003; 22: 3813-20.
57. Lee D, Kim HZ, Jeong KW, et al. Human papillomavirus E2 downregulates the human telomerase reverse transcriptase promoter. J Biol Chem 2002; 277: 27748-56.
58. Yuan H, Veldman T, Rundell K, Schlegel R. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 2002; 76: 10685-91.
59. Van Hoof C, Goris J. PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 2004; 5: 105-6.
60. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 2004; 5: 127-36.
61. Janssens V, Goris J, Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 2005; 15: 34-41.
62. 62. Yang CT, Song J, Bu X, et al. Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther 2003; 10: 1494-502.
63. 63. Verma SC, Borah S, Robertson ES. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol 2004; 78: 10348-59.
64. 64. Yang J, Deng X, Deng L, Gu H, Fan W, Cao Y. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. J Exp Clin Cancer Res 2004; 23: 495-506.
65. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. Cancer Res 2003; 63: 2982-9.
66. 66. Chen F, Liu C, Lindvall C, Xu D, Ernberg I. Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines. M J Cancer 2005; 113: 284-9.
67. Bakalova R, Ohba H, Zhelev Z, et al. Atypical protein-kinase Czeta, but neither conventional Ca2+-dependent protein-kinase C isoenzymes nor Ca2+-calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells. Cancer Chemother Pharmacol 2004; 54: 161-72.
68. Tsumuki H, Nakazawa M, Hasunuma T, et al. Infection of synoviocytes with HTLV-I induces telomerase activity. Rheumatol Int 2001; 20: 175-9.
69. Vignoli M, Stecca B, Furlini G, et al. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients. AIDS 1998; 12: 999-1005.
70. Nichols WS, Schneider S, Chan RC, Farthing CF, Daar ES. Increased CD4+ T-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection. Scand J Immunol 1999; 49: 302-6.
71. Ballon G, Ometto L, Righetti E, et al. Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis 2001; 183: 417-24.
72. Sinha-Datta U, Horikawa I, Michishita E, et al. Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood 2004; 104: 2523-31.
73. Franzese O, Comandini A, Adamo R, Sgadari C, Ensoli B, Bonmassar E. HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells. Cell Death Differ 2004; 11: 782-4.
74. Ouyang X, Cheng R, Feng D, Zheng H. Effect of hepatitis C virus nonstructural protein NS3 on telomerase activity. Zhonghua Bing Li Xue Za Zhi 2001; 30: 443-7.
75. Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 2000; 271: 197-204.
76. Horikawa I, Barrett JC. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst 2001; 93: 1171-3.
77. Zhou W, Shen Q, Gu B, Ren H, Zhang D. Effects of hepatitis B virus X gene on apoptosis and the activity of telomerase in HepG (2) cells. Zhonghua Can Zang Bing Za Zhi 2000; 8: 212-4.
78. Qu ZL, Zou SQ, Wang X. The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines. Zhonghua Wai Ke Za Zhi 2004; 42: 1254-7.
79. Chen HY, Tang NH, Li XJ, Zhang SJ, Chen ZX, Wang XZ. Transfection and expression of hepatitis B virus × gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol 2004; 10: 959-64.
80. Zou SQ, Qu ZL, Li ZF, Wang X. Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. World J Gastroenterol 2004; 10: 2259-62.
81. Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001; 75: 215-25.
82. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742-5.
83. Kwon JA, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Biol Chem 2003; 384: 203-12.
84. Choi M, Lee H, Rho HM. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter. IUBMB Life 2002; 53: 309-17.
85. Djeraba-Ait Lounis A, Soubieux D, Klapper W, Rasschaert D. Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1. Vet Pathol 2004; 41: 405-7.
86. Djeraba-Ait Lounis, Rasschaert D. XIIth International Congress of Virology, Paris. 2002.
87. Fragnet L, Kut E, Rasschaert D. Comparative functional study of the viral telomerase RNA based on natural mutations. J Biol Chem 2005; 280: 23502-15.